Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial

This study assessed the efficacy of insulin degludec/liraglutide (IDegLira) vs insulin glargine U100 (IGlar) across categories of baseline glycated haemoglobin (HbA1c; ≤7.5%, >7.5% to ≤8.5% and >8.5%), body mass index (BMI; <30, ≥30 to <35 and ≥35 kg/m(2)) and fasting plasma glucose (FPG...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Obes Metab
Hlavní autoři: Lingvay, Ildiko, Harris, Stewart, Jaeckel, Elmar, Chandarana, Keval, Ranthe, Mattis F., Jódar, Esteban
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2017
Témata:
Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5763397/
https://ncbi.nlm.nih.gov/pubmed/28643425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13043
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky